Evidence-based diuretics: focus on chlorthalidone and indapamide

Papers of special note have been highlighted as: • of interest

References

• 1 Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117(4), e25–e146 (2008).
  MedlineGoogle Scholar
• 2 Roush GC, Kaur R, Ernst ME. Diuretics: a review and update. J. Cardiovasc. Pharmacol. Ther. 19(1), 5–13 (2014).
  Medline CASGoogle Scholar
• 3 James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5), 507–520 (2014).
  Medline CASGoogle Scholar
• 4 Dinicolantonio JJ. Hydrochlorothiazide: is it a wise choice? Expert Opin. Pharmacother. 13(6), 807–814 (2012).
  Medline CASGoogle Scholar
• 5 Hackam DG, Quinn RR, Ravani P et al. The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can. J. Cardiol. 29(5), 528–542 (2013).
  MedlineGoogle Scholar
• 6 NICE. Hypertension: the clinical management of primary hypertension in adults. CG127/NICE Guideline. National Clinical Guideline Centre. www.guidance.nice.org.uk/cg127.
  Google Scholar
• 7 Capps J, Wiggins W, Axelrod D et al. The effect of mercurial diuretics on the excretion of water. Circulation 6(1), 82–89 (1952).
  Medline CASGoogle Scholar
• 8 Novello FC, Sprague JM. Benzothiadiazine dioxides as novel diuretics. J. Am. Chem. Soc. 79(8), 2028–2029 (1957).
  CASGoogle Scholar
• 9 Freis E, Wanko A, Wilson IM et al. Treatment of essential hypertension with chlorothiazide (Diuril). JAMA 166(2), 137–140 (1958).
  Medline CASGoogle Scholar
• 10 Moser M, Macauley AI. Chlorothiazide as an adjunct in the treatment of essential hypertension. Am. J. Cardiol. 3(2), 214–219 (1959).
  Medline CASGoogle Scholar
• 11 Reilly RF, Ellison DH. Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol. Rev. 80, 277–313 (2000).
  Medline CASGoogle Scholar
• 12 Hughes AD. How do thiazide and thiazide-like diuretics lower blood pressure? J. Renin Angiotensin Aldosterone Syst. 5(4), 155–160 (2004).
  Medline CASGoogle Scholar
• 13 Aung K, Htay T. Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst. Rev. (10), CD005185 (2011).
  MedlineGoogle Scholar
• 14 Ernst ME, Carter BL, Goerdt CJ et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47, 352–358 (2006).
  Medline CASGoogle Scholar
• 15 Allen JH, McKenney JM, Stratton MA et al. Antihypertensive effect of hydrochlorthiazide administered once or twice daily. Clin. Pharm. 1, 239–243 (1982).
  Medline CASGoogle Scholar
• 16 Mironneau J, Savineau JP, Mironneau C. Compared effects of indapamide, hydrochlorothiazide and chlorthalidone on electrical and mechanical activities in vascular smooth muscle. Eur. J. Pharmacol. 75, 109–113 (1981).
  Medline CASGoogle Scholar
• 17 Cooper-DeHoff JD. Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev. Cardiovasc. Ther. 8(6), 793–802 (2010).
  MedlineGoogle Scholar
• 18 Madkour H, Gadallah M, Riveline B et al. Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. Am. J. Cardiol. 77, 23B–25B (1996).
  Medline CASGoogle Scholar
• 19 Carey PA, Sheridan DJ, de Cordoue A et al. Effect of indapamide on left ventricular hypertrophy in hypertension: a meta-analysis. Am. J. Cardiol. 77, 17B–19B (1996).
  Medline CASGoogle Scholar
• 20 Emeriau JP, Knauf H, Pujadas JO et al. A comparison of indapamide SR 1.5mg with both amlodipine 5mg and hydrochlorothiazide 25mg in elderly hypertensive patients: a randomized double-blind controlled study. J. Hypertens. 19(2), 343–350 (2001).
  Medline CASGoogle Scholar
• 21 Ernst ME, Neaton JD, Grimm RH Jr et al. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial. Hypertension 58(6), 1001–1007 (2011).
  Medline CASGoogle Scholar
• 22 Woodman R, Brown C, Lockette W. Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension 56(3), 463–470 (2010).
  Medline CASGoogle Scholar
• 23 Mogensen CE, Viberti G, Halimi S et al. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. Hypertension 41(5), 1063–1071 (2003).
  Medline CASGoogle Scholar
• 24 Ernst ME, Moser M. Use of diuretics in patients with hypertension. N. Engl. J. Med. 361, 2153–2164 (2009).
  Medline CASGoogle Scholar
• 25 National Collaborating Centre for Chronic Conditions. Hypertension: Management in Adults in Primary Care: Pharmacological Update. Royal College of Physicians, London, UK (2006).
  Google Scholar
• 26 Boscoe A, Paramore C, Verbalis JG. Cost of illness of hyponatremia in the United States. Cost Eff. Resour. Alloc. 4, 10 (2006).
  MedlineGoogle Scholar
• 27 Callahan MA, Do HT, Caplan DW et al. Economic impact of hyponatremia in hospitalized patients: a retrospective cohort study. Postgrad. Med. 121(2), 186–191 (2009).
  MedlineGoogle Scholar
• 28 Shea AM, Hammill BG, Curtis LH et al. Medical costs of abnormal serum sodium levels. J. Am. Soc. Nephrol. 19, 764–770 (2008).
  Medline CASGoogle Scholar
• 29 Zilberberg MD, Exuzides A, Spalding J et al. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr. Med. Res. Opin. 24, 1601–1608 (2008).
  MedlineGoogle Scholar
• 30 Leung AA, Wright A, Pazo V, Karson A, Bates DW. Risk of thiazide induced hyponatremia in patients with hypertension. Am. J. Med. 124(11), 1064–1072 (2011).
  Medline CASGoogle Scholar
• 31 Decaux G. Is asymptomatic hyponatremia really asymptomatic? Am. J. Med. 119(7 Suppl. 1), S79–S82 (2006).
  MedlineGoogle Scholar
• 32 GankamKengne F, Andres C, Sattar L et al. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 101(7), 583–588 (2008).
  Medline CASGoogle Scholar
• 33 Dhalla IA, Gomes T, Yao Z et al. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study. Ann. Intern. Med. 158(6), 447–455 (2013).
  MedlineGoogle Scholar
• 34 Chan TY. Indapamide-induced severe hyponatraemia and hypokalaemia. Ann. Pharmacother. 29(11), 1124–1128 (1995).
  Medline CASGoogle Scholar
• 35 Yong TY, Huang JE, Lau SY et al. Severe hyponatremia and other electrolyte disturbances associated with indapamide. Curr. Drug Saf. 6(3), 134–137 (2011).
  Medline CASGoogle Scholar
• 36 Chapman MD, Hanrahan R, McEwen J et al. Hyponatraemia and hypokalaemia due to indapamide. Med. J. Aust. 176(5), 219–221 (2002).
  MedlineGoogle Scholar
• 37 Hoes AW, Grobbee DE, Lubsen J. Sudden cardiac death in patients with hypertension: an association with diuretics and beta-blockers? Drug Saf. 16(4), 233–241 (1997).
  Medline CASGoogle Scholar
• 38 Cohen JD, Neaton JD, Prineas RJ et al. Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial. Am. J. Cardiol. 60(7), 548–554 (1987).
  Medline CASGoogle Scholar
• 39 Cushman WC, Khatri I, Materson BJ et al. Treatment of hypertension in the elderly. III. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: results of a Department of Veterans Affairs cooperative study. Arch. Intern. Med. 151(10), 1954–1960 (1991).
  Medline CASGoogle Scholar
• 40 Alderman MH, Piller LB, Ford CE et al. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Hypertension 59(5), 926–933 (2012).
  Medline CASGoogle Scholar
• 41 Ernst ME, Carter BL, Zheng S et al. Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am. J. Hypertens. 23(4), 440–446 (2010).
  Medline CASGoogle Scholar
• 42 Plante GE, Robillard C. Indapamide in the treatment of essential arterial hypertension: results of a controlled study. Curr. Med. Res. Opin. 8(Suppl. 3), 59–66 (1983).
  MedlineGoogle Scholar
• 43 Ambrosioni E, Safar M, Degaute JP et al. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomized doubleblind controlled studies. European study group. J. Hypertens. 16(11), 1677–1684 (1998).
  Medline CASGoogle Scholar
• 44 Sica DA, Schoolwerth A. Renal handing of organic anions and cations and renal excretion of uric acid. In: The Kidney. Brenner B, Rector F (Eds). WB Saunders, PA, USA, 637–662 (2004).
  Google Scholar
• 45 Dorsch MP, Gillespie BW, Erickson SR et al. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension 57(4), 689–694 (2011).
  Medline CASGoogle Scholar
• 46 Franse LV, Pahor M, Di Bari M et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J. Hypertens. 18(8), 1149–1154 (2000).
  Medline CASGoogle Scholar
• 47 Myers MG, Asmar R, Leenen FH et al. Fixed low-dose combination therapy in hypertension: a dose response study of perindopril and indapamide. J. Hypertens. 18(3), 317–325 (2000).
  Medline CASGoogle Scholar
• 48 Kreeft JH, Langlois S, Ogilvie RI. Comparative trial of indapamide and hydrochlorothiazide in essential hypertension with forearm plethysmography. J. Cardiovasc. Pharmacol. 6(4), 622–626 (1984).
  Medline CASGoogle Scholar
• 49 Elliott WJ, Weber RR, Murphy MB. A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide. J. Clin. Pharmacol. 31(8), 751–757 (1991).
  Medline CASGoogle Scholar
• 50 Savage PJ, Pressel SL, Curb JD et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. Arch. Intern. Med. 158(7), 741–751 (1998).
  Medline CASGoogle Scholar
• 51 Zillich AJ, Garg J, Basu S et al. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 48(2), 219–224 (2006).
  Medline CASGoogle Scholar
• 52 Manrique C, Giles TD, Ferdinand KC et al. Realities of newer β-blockers for the management of hypertension. J. Clin. Hypertens. (Greenwich) 11(7), 369–375 (2009).
  Medline CASGoogle Scholar
• 53 Stears AJ, Woods SH, Watts MM et al. A double-blind, placebocontrolled, crossover trial comparing the effects of amiloride and hydrochlorothiazide on glucose tolerance in patients with essential hypertension. Hypertension 59(5), 934–942 (2012).
  Medline CASGoogle Scholar
• 54 Mantel-Teeuwisse AK, Kloosterman JM, Maitland-van der Zee AH et al. Drug induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Saf. 24(6), 443–456 (2001).
  Medline CASGoogle Scholar
• 55 Lakshman MR, Reda DJ, Materson BJ et al. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch. Intern. Med. 159(6), 551–558 (1999).
  Medline CASGoogle Scholar
• 56 Kostis JB, Wilson AC, Freudenberger RS et al. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am. J. Cardiol. 95(1), 29–35 (2005).
  Medline CASGoogle Scholar
• 57 Peer R, Black HR, Davis B et al. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care 31(2), 353–360 (2008).
  MedlineGoogle Scholar
• 58 Ames RP. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides. Am. J. Cardiol. 77(6), B12–B16 (1996).
  Google Scholar
• 59 Puig JG, Marre M, Kokot F et al. Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with Type 2 diabetes. Am. J. Hypertens. 20(1), 90–97 (2007).
  Medline CASGoogle Scholar
• 60 Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies. Drug Saf. 24(15), 1155–1165 (2001).
  Medline CASGoogle Scholar
• 61 Roush GC, Holford TR, Guddati AK. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension 59(6), 1110–1117 (2012).• Chlorthalidone superior to hydrochlorothiazide for reducing cardiovascular events.
  Medline CASGoogle Scholar
• 62 SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265(24), 3255–3264 (1991).
  MedlineGoogle Scholar
• 63 Patel A, Macmahon S, Chalmers J et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with Type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 370(9590), 829–840 (2007).
  Medline CASGoogle Scholar
• 64 de Galan BE, Perkovic V, Ninomiya T et al. Lowering blood pressure reduces renal events in Type 2 diabetes. J. Am. Soc. Nephrol. 20(4), 883–892 (2009).
  Medline CASGoogle Scholar
• 65 PROGRESS Collaborative Group. Randomised trial of a peridopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358(9287), 1033–1041 (2001).
  MedlineGoogle Scholar
• 66 Beckett NS, Peters R, Fletcher AE et al. Treatment of hypertension in patients 80 years of age or older. N. Engl. J. Med. 358(18), 1887–1898 (2008).
  Medline CASGoogle Scholar
• 67 PATS Collaborating Group. Post-stroke antihypertensive treatment study: a preliminary result. Chin. Med. J. (Engl.) 108(9), 710–717 (1995).
  MedlineGoogle Scholar
• 68 Messerli FH, Bangalore S, Julius S. Risk/benefit assessment of beta- blockers and diuretics precludes their use for first-line therapy in hypertension. Circulation 117(20), 2706–2715 (2008).
  MedlineGoogle Scholar
• 69 Messerli FH, Makani H, Benjo A et al. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. J. Am. Coll. Cardiol. 57(5), 590–600 (2011).
  Medline CASGoogle Scholar
• 70 Materson BJ, Cushman WC, Goldstein G et al. Treatment of hypertension in the elderly. I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative study. Hypertension 15(4), 348–360 (1990).
  Medline CASGoogle Scholar
• 71 Wing LM, Reid CM, Ryan P et al. A comparison of outcomes with angiotensin- converting enzyme inhibitors and diuretics for hypertension in the elderly. N. Engl. J. Med. 348(7), 583–592 (2003).
  Medline CASGoogle Scholar
• 72 Jamerson K, Weber MA, Bakris GL et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N. Engl. J. Med. 359(23), 2417–2428 (2008).
  Medline CASGoogle Scholar
• 73 Leren P, Helgeland A. Oslo hypertension study. Drugs 31(Suppl. 1), 41–45 (1986).• Hydrochlorothiazide increases cardiovascular mortality compared with placebo.
  MedlineGoogle Scholar
• 74 The Management Committee. The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet 1(8181), 1261–1267 (1980).
  MedlineGoogle Scholar
• 75 Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 202(11), 1028–1034 (1967).
  MedlineGoogle Scholar
• 76 Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 213(7), 1143–1152 (1970).
  MedlineGoogle Scholar
• 77 Amery A, Birkenhager W, Brixko P et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1(8442), 1349–1354 (1985).
  Medline CASGoogle Scholar
• 78 O'Malley K, Cox JP, O'Brien E. Further learnings from the European Working Party on High Blood Pressure in the Elderly (EWPHE) study: focus on systolic hypertension. Cardiovasc. Drugs Ther. 4(Suppl. 6), 1249–1251 (1991).
  MedlineGoogle Scholar
• 79 Wilhelmsen L, Berglund G, Elmfeldt D et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J. Hypertens. 5(5), 561–572 (1987).
  Medline CASGoogle Scholar
• 80 De Leeuw PW, Ruilope LM, Palmer CR et al. Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial. Arch. Intern. Med. 164(22), 2459–2464 (2004).
  MedlineGoogle Scholar
• 81 Simon A, Gariepy J, Moyse D et al. Differential effects of nifedipine and co-amilozide on the porgression of early carotid wall changes. Circulation 103(24), 2949–2954 (2001).
  Medline CASGoogle Scholar
• 82 Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242(33), 2562–2571 (1979).
  MedlineGoogle Scholar
• 83 The Multiple Risk Factor Intervention Trial Research Group. Mortality after 10½ years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 82(5), 1616–1628 (1990).
  MedlineGoogle Scholar
• 84 The Multiple Risk Factor Intervention Trial Research Group. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priority hypotheses of the trial. JAMA 263(13), 1795–1801 (1990).
  MedlineGoogle Scholar
• 85 Neaton JD, Grimm RH Jr, Prineas RJ et al. Treatment of Mild Hypertension Study: final results. Treatment of Mild Hypertension Study Research Group. JAMA 270(6), 713–724 (1993).
  Medline CASGoogle Scholar
• 86 Zanchetti A, Rosei EA, Dal Palu C et al. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. J. Hypertens. 16(11), 1667–1676 (1998).
  Medline CASGoogle Scholar
• 87 ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trail (ALLHAT). JAMA 288(23), 2981–2997 (2002).
  MedlineGoogle Scholar
• 88 Gosse P, Sheridan DJ, Zannad F et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. J. Hypertens. 18(10), 1465–1475 (2000).
  Medline CASGoogle Scholar
• 89 Baguet JP, Robitail S, Boyer L et al. A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Am. J. Cardiovasc. Drugs 5(2), 131–140 (2005).
  Medline CASGoogle Scholar
• 90 London G, Schmieder R, Calvo C et al. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study. Am. J. Hypertens. 19(1), 113–121 (2006).
  Medline CASGoogle Scholar
• 91 Akram J, Sheikh UE, Mahmood M et al. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study. Curr. Med. Res. Opin. 23(12), 2929–2936 (2007).
  Medline CASGoogle Scholar
• 92 Kang S, Wu YF, An N et al. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension. Clin. Ther. 26(2), 257–270 (2004).
  Medline CASGoogle Scholar
• 93 Ghiadoni L, Magagna A, Kardasz I et al. Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. Am. J. Hypertens. 22(5), 506–512 (2009).
  Medline CASGoogle Scholar
• 94 Asmar RG, London GB, O'Rourke ME et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 38(4), 922–926 (2001).
  Medline CASGoogle Scholar
• 95 Dahlof B, Gosse P, Gueret P et al. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J. Hypertens. 23(11), 2063–2070 (2005).
  MedlineGoogle Scholar
• 96 de Luca N, Mallion JM, O'Rourke MF et al. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. Am. J. Hypertens. 17(8), 660–667 (2004).
  Medline CASGoogle Scholar
• 97 Marre M, Puig JG, Kokot F et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with Type 2 diabetes: the NESTOR Study. J. Hypertens. 22(8), 1613–1622 (2004).
  Medline CASGoogle Scholar
• 98 Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting theirinterchangeability. Hypertension 43(1), 4–9 (2004).
  Medline CASGoogle Scholar
• 99 Kuo SW, Pei-Dee, Hung YJ et al. Effect of indapamide SR in the treatment of hypertensive patients with Type 2 diabetes. Am. J. Hypertens. 16(8), 623–628 (2008).
  Google Scholar
• 100 Vinereanu D, Dulgheru R, Magda S et al. The effect of Indapamide versus Hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: results of a randomized trial. Am. Heart J. 168(4), 446–456 (2014).
  Medline CASGoogle Scholar